Severe Hypocalcemia due to Denosumab in Metastatic Prostate Cancer

Denosumab is a monoclonal antibody used for prevention of skeletal-related events (SREs) in patients with bone metastases from solid tumors. Hypocalcemia is a rare and dangerous side effect of the drug Denosumab. We present a case of a patient with metastatic prostate cancer who developed severe hyp...

Descripción completa

Detalles Bibliográficos
Autores principales: Muqeet Adnan, Mohammed, Bhutta, Usman, Iqbal, Tanzeel, AbdulMujeeb, Sufyan, Haragsim, Lukas, Amer, Syed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099037/
https://www.ncbi.nlm.nih.gov/pubmed/25054070
http://dx.doi.org/10.1155/2014/565393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099037/
https://www.ncbi.nlm.nih.gov/pubmed/25054070
http://dx.doi.org/10.1155/2014/565393

Ejemplares similares